Gateway Investment Advisers’s Roivant Sciences ROIV Stock Holding History

Gateway Investment Advisers’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$379K	Buy	+10,716	New	+$317K	﹤0.01%	659

Other funds holding ROIV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PDM

Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Cache Advisors San Francisco, California $1.18B AUM 44.04% 1-Year Est. Return

Gateway Investment Advisers's ROIV Position: Q2 2026 in Review

Gateway Investment Advisers opened a new position in Roivant Sciences (ROIV) in Q2 2026: 10,716 shares worth $379K. The stake represents ﹤0.01% of the portfolio and ranks #659 among its holdings.

167 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Gateway Investment Advisers held 10,716 shares of Roivant Sciences worth $379K as of Q2 2026.
Roivant Sciences was a new Gateway Investment Advisers position in Q2 2026.
Roivant Sciences made up ﹤0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #659 holding.
167 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.